News
August 2013

The US Physician Payment Sunshine Act: implications for multinational drug and device manufacturers

Practical Law Company's Practical Law Multi-Jurisdictional Guide 2013: Life Sciences

By Daniel A. Kracov
Find more content tagged:

People

Daniel A. Kracov
Daniel A. Kracov
Partner
Washington, DC
+1 202.942.5120
Email
VCard

Related Content

July 2, 2021
The VALID Act & 21st Century Cures 2.0: What Industry Needs to Know
Advisory
June 11, 2021
White House Details Supply Chain Security and Resiliency Plans: What Pharmaceutical Manufacturers Need to Know
Advisory
June 9, 2021
FDA Releases Guidance on the Drug Supply Chain Security Act
Advisory
Subscribe
Subscribe Link

Email Disclaimer

Reject Accept